Risk factors

Phio Pharmaceuticals emphasizes risks regarding capital requirements, Nasdaq minimum bid compliance, and third-party manufacturing dependencies for its drug candidates.

The company added a risk regarding the adoption of AI technologies.

Total debt increased to $39.5 million and credit facility availability dropped to $52.0 million. Tariffs on steel and aluminum remain a primary margin risk despite the 2026 Supreme Court ruling on IEEPA. Artificial intelligence is being evaluated for internal company use.

Arroweye integration, product innovation and market competition are newly highlighted business risks.

Profound Medical added GDPR and international tariff risks, updated share counts for options and RSUs, and referenced cGMP manufacturing standards.

CarParts faces severe financial strain with $3,690 in impairment charges, convertible note dilution, and a reduced credit facility.

Rand Capital added risks detailing its adoption of 150% asset coverage leverage under the SBCAA. The company highlighted potential impacts from changing U.S. political and regulatory policies under the Trump administration.

Accumulated deficit increased to $127.6 million with cash dropping to $0.7 million by the end of 2025.

Concentration in the Permian Basin creates heightened exposure to regional weather, pricing, and infrastructure constraints. Discretionary dividends and share repurchases carry no guarantees and depend on board approval. E&P customer activities face tighter federal methane and wastewater discharge rules.

Rumble expanded its risk disclosures to cover the proposed Northern Data business combination, new crypto and AI initiatives, and stricter age verification laws.

Rayonier Advanced Materials added risks regarding AI adoption and strategic execution while updating tax asset realizations in Canada.

SandRidge Energy faces revenue concentration risks from a few major customers and needs successful acquisitions or exploration to offset natural reserve declines.